PENG — what changed in the latest 10-Q
A section-by-section comparison of PENG's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-07-07 vs the prior 10-Q · 2026-04-01
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +22 | −19 | ~21 | 25 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~2 | 7 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 7 |
| Legal proceedings | Text added/removed | 0 | 0 | ~2 | 7 |
| Risk factors | Text added/removed | 0 | 0 | ~2 | 7 |
| Other information | Text added/removed | 0 | 0 | ~2 | 7 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-07-07
Cost of sales increased by $116.3 million, or 50.8%, and $108.4 million, or 14.8%, in the third quarter and first nine months of 2026, respectively, compared to the same periods in the prior year. The increase was primarily driven by strong growth for our Integrated Memory segment.
Research and development expense increased by $1.8 million, or 8.7%, and decreased by $0.3 million, or 0.5%, in the third quarter and first nine months of 2026, respectively, as compared to the same periods in the prior year, with the third-quarter increase reflecting higher incentive compensation t…
Net interest expense decreased by $5.7 million in the first nine months of 2026 compared to the same period in the prior year, primarily due to the full repayment of the Amended 2022 TLA (as defined below) in the fourth quarter of 2025.
Other non-operating (income) expense in the first nine months of 2026 includes a net gain of $30.9 million from the disposition of equity investments, partially offset by a $10.0 million charge on impairment of a non-marketable equity investment. See “Item 1. Financial Statements – Notes to Consolid…
In addition, other non-operating (income) expense in the first nine months of 2026 and 2025 included foreign currency gains (losses). See “Item 1. Financial Statements – Notes to Consolidated Financial Statements – Other Non-operating (Income) Expense.”
Text removed vs the prior filing · source: 10-Q · 2026-04-01
Cost of sales decreased by $11.6 million, or 4.4%, and $7.9 million, or 1.6%, in the second quarter and first six months of 2026, respectively, compared to the same periods in the prior year. The decrease was primarily driven by lower sales from our Advanced Computing segment in the second quarter o…
Research and development expense decreased by $0.9 million, or 4.7%, and $2.0 million, or 5.2%, in the second quarter and first six months of 2026, respectively, as compared to the same periods in the prior year, primarily due to lower personnel-related expenses mainly driven by headcount reductions…
wind down of our Penguin Edge business. We anticipate that such activities will continue into future quarters, for which we expect to record additional restructuring charges.
Net interest expense decreased by $5.8 million in the first six months of 2026 compared to the same period in the prior year, primarily due to the full repayment of the Amended 2022 TLA (as defined below) in the fourth quarter of 2025.
Other non-operating (income) expense in the first six months of 2026 includes a net gain of $27.0 million from the disposition of equity investments, partially offset by a $10.0 million charge on impairment of a non-marketable equity investment. See “Item 1. Financial Statements – Notes to Consolida…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice